From: Guidance to best tools and practices for systematic reviews
 | Intervention | Diagnostic | Prognostic | Qualitative or mixed methods | Prevalence and Incidence | Etiology and Risk | Measurement Properties | Overviews (umbrella reviews) | Scoping Reviews |
---|---|---|---|---|---|---|---|---|---|
Methodological guidance | Cochraneb, JBI | Cochrane, JBI | Cochrane | Cochrane, JBI | JBI | JBI | JBI | Cochrane, JBI | JBI |
Reportingc | |||||||||
 Protocol | PRISMA-P [116] | PRISMA-P | PRISMA-P | PRISMA-P | PRISMA-P | PRISMA-P | PRISMA-P | PRISMA-P | PRISMA-P |
 Systematic review | PRISMA 2020 [112] | PRISMA-DTA [120] | PRISMA 2020 | eMERGe [213]d ENTREQ [214]d | PRISMA 2020 | PRISMA 2020 | PRISMA 2020 | PRIOR [215] | PRISMA-ScR [121] |
 Synthesis without MA | SWiM [180] | PRISMA-DTA [120] | SWiMe | eMERGe [213]d ENTREQ [214]d | SWiMe | SWiMe | SWiMe | PRIOR [215] | |
RoB assessment of included studiesf | For RCTs: Cochrane RoB2 [157] For NRSI: ROBINS-I [158] Other primary researchg | QUADAS-2[216] | Factor review QUIPS [217] Model review PROBAST [65] | CASP qualitative checklist [218] JBI Critical Appraisal Checklist [219]h | JBI checklist for studies reporting prevalence data [220] | For NRSI: ROBINS-I [158] Other primary researchg | COSMIN RoB Checklist [67] | Not requiredi | |
Overall level of evidence certainty | GRADE [27] | GRADE adaptationj | GRADE adaptationk | CERQual [221] ConQual [222]l | GRADE adaptationm | Risk factorsn | GRADE adaptationo | GRADE (for intervention reviews) Risk factorsn | Not applicable |